TWST
Twist Bioscience Corporation
Set alert
- YTD
- +381.65%
- 1 year
- +390.15%
- Open
- 161.39
- Prev close
- 173.45
- Mkt cap
- 10.13B
- Vol
- 3.40M
- Avg vol
- 2.30M
- EPS
- -2.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 148.00
- High
- 167.27
- Forward P/E
- -381.95
- Beta
- 2.19
- Short ratio
- 3.22
- Inst. own
- 116.96%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 152.78
- 200-d avg
- 88.45
- 1y target
- 168.25
Discussion (3)
Sign in to join the discussion
Keep calm, it is a long time story. insider are selling because of super Performance so far.
What a strong recovery, wow
$OBSV
Don’t mis this run. Lots of upside potential.
ObsEva SA (NASDAQ:OBSV) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Shareholders will be ecstatic, with their stake up 30% over the past week following ObsEva SA‘s (NASDAQ:OBSV) latest quarterly results. Revenues came in 113% better than analyst models expected, at US$4.0kwhile statutory losses per share were US$0.48, in line with forecasts. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.